322 related articles for article (PubMed ID: 27151884)
1. Characterization of the immune response induced by pertussis OMVs-based vaccine.
Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
[TBL] [Abstract][Full Text] [Related]
2. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
[TBL] [Abstract][Full Text] [Related]
4. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
[No Abstract] [Full Text] [Related]
5. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
[TBL] [Abstract][Full Text] [Related]
6. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
[TBL] [Abstract][Full Text] [Related]
7. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles.
Ormazábal M; Bartel E; Gaillard ME; Bottero D; Errea A; Zurita ME; Moreno G; Rumbo M; Castuma C; Flores D; Martín MJ; Hozbor D
Vaccine; 2014 Oct; 32(46):6084-90. PubMed ID: 25240753
[TBL] [Abstract][Full Text] [Related]
9. Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against
Bottero D; Zurita ME; Gaillard ME; Carriquiriborde F; Martin Aispuro P; Elizagaray M; Bartel E; Castuma C; Hozbor D
Front Immunol; 2018; 9():2501. PubMed ID: 30459769
[No Abstract] [Full Text] [Related]
10. Immunogenicity and protective potential of Bordetella pertussis biofilm and its associated antigens in a murine model.
Dorji D; Graham RM; Singh AK; Ramsay JP; Price P; Lee S
Cell Immunol; 2019 Mar; 337():42-47. PubMed ID: 30770093
[TBL] [Abstract][Full Text] [Related]
11. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
[TBL] [Abstract][Full Text] [Related]
13. Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.
Carriquiriborde F; Martin Aispuro P; Ambrosis N; Zurita E; Bottero D; Gaillard ME; Castuma C; Rudi E; Lodeiro A; Hozbor DF
Front Immunol; 2021; 12():730434. PubMed ID: 34603306
[TBL] [Abstract][Full Text] [Related]
14. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of efficacy in terms of antibody levels and cell-mediated immunity of acellular pertussis vaccines in a murine model of respiratory infection.
Watanabe M; Komatsu E; Sato T; Nagai M
FEMS Immunol Med Microbiol; 2002 Jul; 33(3):219-25. PubMed ID: 12110485
[TBL] [Abstract][Full Text] [Related]
16. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J
Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007
[TBL] [Abstract][Full Text] [Related]
17. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
[TBL] [Abstract][Full Text] [Related]
18. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
[TBL] [Abstract][Full Text] [Related]
19. Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.
Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H
Curr Pharm Biotechnol; 2017; 18(7):585-593. PubMed ID: 28814229
[TBL] [Abstract][Full Text] [Related]
20. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
Lavigne MV; Castro M; Andino J; Manghi M
Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]